RSNA is dedicated to ensuring that all attendees have a healthier and safer meeting experience.
To ensure the safety of everyone in attendance at the annual meeting, RSNA is requiring proof of full COVID-19 vaccination from all meeting attendees, staff and exhibitor personnel prior to admittance into McCormick Place.
Acceptable vaccinations are those with U.S. Food & Drug Administration (FDA) or World Health Organization (WHO) approval or emergency use authorization.
Before the meeting, all participants will be required to complete vaccination verification via a free, downloadable app, CLEAR, for domestic participants or the website, Safe Expo, for international participants.
McCormick Place has enhanced its cleaning protocols and added safety measures like touch-free doors, improved air quality, hand sanitizing stations and entry and exit processes to provide a safe environment. Face masks will be required in all public indoor places, including RSNA-provided shuttle buses, Metra trains, rideshares, etc., regardless of the status of mask mandates outside of RSNA 2021. All participants are encouraged to practice good hygiene and refrain from entering McCormick Place if you are feeling unwell or experiencing COVID-19 symptoms.
RSNA will offer two onsite COVID-19 testing options during RSNA 2021:
- Rapid Antigen, for attendees who are feeling unwell. Results provided within 15 minutes.
- Rapid Molecular, for attendees who require a negative COVID-19 test for travel or to return to work. This test satisfies most country and airline requirements for travel.
Your results will be available within 60 minutes of your testing appointment (printed or securely emailed to you).
Appointments can be scheduled in advance at RSNA.org/Covid-Testing. Walk-ins are also welcome. Please note, there may be a fee required for testing.
For updated information, visit the Health & Safety page at Meeting.RSNA.org.